These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35255407)

  • 1. NEURO TOUCH: A novel digital device for assessment and screening of peripheral neuropathy.
    Riddhi D; Jebasingh F; Thomas N; Kn M; Sharma S; Saravanan B
    Foot (Edinb); 2022 May; 51():101888. PubMed ID: 35255407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NerveCheck: An inexpensive quantitative sensory testing device for patients with diabetic neuropathy.
    Ponirakis G; Odriozola MN; Odriozola S; Petropoulos IN; Azmi S; Fadavi H; Alam U; Asghar O; Marshall A; Miro A; Kheyami A; Al-Ahmar A; Odriozola MB; Odriozola A; Malik RA
    Diabetes Res Clin Pract; 2016 Mar; 113():101-7. PubMed ID: 26830855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological diagnosis--aspects of quantitative sensory testing methodology in relation to hand-arm vibration syndrome.
    Lundström R
    Int Arch Occup Environ Health; 2002 Jan; 75(1-2):68-77. PubMed ID: 11898879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensory perception threshold measurement: an evaluation of semiobjective testing devices.
    Halar EM; Hammond MC; LaCava EC; Camann C; Ward J
    Arch Phys Med Rehabil; 1987 Aug; 68(8):499-507. PubMed ID: 3619613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of SET--a new device for the measurement of pain perception in comparison to standard measures of diabetic neuropathy.
    Nguyen M; Henniges W; Lobisch M; Reifert S; Larbig M; Pfützner A; Forst T
    Diabetes Technol Ther; 2004 Oct; 6(5):601-6. PubMed ID: 15628814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the diagnostic accuracy of Vibrasense compared to a biothesiometer and nerve conduction study for screening diabetic peripheral neuropathy.
    Sharma K N S; Kumar H A
    J Foot Ankle Res; 2023 Sep; 16(1):65. PubMed ID: 37770911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal Malignancies.
    Reddy SM; Vergo MT; Paice JA; Kwon N; Helenowski IB; Benson AB; Mulcahy MF; Nimeiri HS; Harden RN
    Clin Colorectal Cancer; 2016 Mar; 15(1):37-46. PubMed ID: 26337211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of clinical tools and their diagnostic use in distal symmetric polyneuropathy.
    Pourhamidi K; Dahlin LB; Englund E; Rolandsson O
    Prim Care Diabetes; 2014 Apr; 8(1):77-84. PubMed ID: 23664849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Accuracy of Clinical Methods for Detection of Diabetic Sensory Neuropathy.
    Arshad AR; Alvi KY
    J Coll Physicians Surg Pak; 2016 May; 26(5):374-9. PubMed ID: 27225141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of a new device in the assessment of peripheral sensory neuropathy in diabetes.
    Bracewell N; Game F; Jeffcoate W; Scammell BE
    Diabet Med; 2012 Dec; 29(12):1553-5. PubMed ID: 22672257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of diabetic peripheral neuropathy with use of the clanging tuning fork test.
    Oyer DS; Saxon D; Shah A
    Endocr Pract; 2007; 13(1):5-10. PubMed ID: 17360294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bedside neuropathy disability score compared to quantitative sensory testing for measurement of diabetic neuropathy in children, adolescents, and young adults with type 1 diabetes.
    Weintrob N; Amitay I; Lilos P; Shalitin S; Lazar L; Josefsberg Z
    J Diabetes Complications; 2007; 21(1):13-9. PubMed ID: 17189869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of sensory testing on different toe surfaces: implications for neuropathy screening.
    Dimitrakoudis D; Bril V
    Neurology; 2002 Aug; 59(4):611-3. PubMed ID: 12196660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative sensory testing: a consensus report from the Peripheral Neuropathy Association.
    Neurology; 1993 May; 43(5):1050-2. PubMed ID: 8388089
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative study of the cutaneous sensation of leprosy-suspected lesions using Semmes-Weinstein monofilaments and quantitative thermal testing.
    Villarroel MF; Orsini MB; Lima RC; Antunes CM
    Lepr Rev; 2007 Jun; 78(2):102-9. PubMed ID: 17824480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical Peripheral Neuropathy in Patients with Head and Neck Cancer: A Quantitative Sensory Testing (QST) Study.
    Roldan CJ; Johnson C; Lee SO; Peng A; Dougherty PM; Huh B
    Pain Physician; 2018 Jul; 21(4):E419-E427. PubMed ID: 30045608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new device to quantify tactile sensation in neuropathy.
    Kennedy WR; Selim MM; Brink TS; Hodges JS; Wendelschafer-Crabb G; Foster SX; Nolano M; Provitera V; Simone DA
    Neurology; 2011 May; 76(19):1642-9. PubMed ID: 21555731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy.
    Freeman R; Chase KP; Risk MR
    Neurology; 2003 Feb; 60(3):465-70. PubMed ID: 12578928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the clinical efficacy of multiple lower-extremity nerve decompression in diabetic peripheral neuropathy.
    Zhang W; Zhong W; Yang M; Shi J; Guowei L; Ma Q
    Br J Neurosurg; 2013 Dec; 27(6):795-9. PubMed ID: 23713665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Automated Tactile Tester for evaluation of cutaneous sensibility.
    Horch K; Hardy M; Jimenez S; Jabaley M
    J Hand Surg Am; 1992 Sep; 17(5):829-37. PubMed ID: 1401790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.